Independent Research set a €39.00 ($45.35) price target on Siemens Healthineers (ETR:SHL) in a research note issued to investors on Tuesday morning. The firm currently has a neutral rating on the stock.
A number of other equities research analysts also recently issued reports on SHL. Kepler Capital Markets set a €38.50 ($44.77) target price on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Tuesday, July 31st. Berenberg Bank set a €42.00 ($48.84) target price on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Monday. Royal Bank of Canada set a €37.00 ($43.02) price target on shares of Siemens Healthineers and gave the company a neutral rating in a report on Monday. Goldman Sachs Group set a €34.50 ($40.12) price target on shares of Siemens Healthineers and gave the company a neutral rating in a report on Monday. Finally, Deutsche Bank set a €38.00 ($44.19) price target on shares of Siemens Healthineers and gave the company a neutral rating in a report on Tuesday, July 31st. Fourteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Siemens Healthineers presently has a consensus rating of Hold and an average target price of €38.37 ($44.61).
SHL stock opened at €37.87 ($44.03) on Tuesday.
Siemens Healthineers Company Profile
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Read More: Average Daily Trade Volume – What You Need to Know
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.